中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

NRS-2002营养评估与肝细胞癌患者肝切除术后无复发生存时间及总生存时间的关系

田甜 张姮 姜挺

引用本文:
Citation:

NRS-2002营养评估与肝细胞癌患者肝切除术后无复发生存时间及总生存时间的关系

DOI: 10.3969/j.issn.1001-5256.2019.09.017
基金项目: 

国家自然科学基金(2016CFB591); 

详细信息
  • 中图分类号: R735.7

Association of Nutritional Risk Assessment 2002 score with recurrence-free survival time and overall survival time in patients undergoing hepatectomy

Research funding: 

 

  • 摘要: 目的探讨营养风险评估表(NRS-2002)与肝细胞癌(HCC)肝切除术患者无复发生存时间及总生存时间之间的关系。方法选取2013年1月-2017年1月在武汉中心医院首次行肝切除术治疗的HCC患者。采用NRS-2002评分评估HCC患者术前的营养状态。所有患者均随访,根据随访结果记录无复发生存时间及总生存时间。计数资料2组间比较采用χ2检验。采用Kaplan-Meier检验对无复发生存时间及总体生存时间进行分析。复发及死亡的独立危险因素采用多因素Cox比例风险模型分析。结果根据NRS-2002评分筛查结果显示,230例HCC患者术前存在营养风险72例,营养正常158例,营养风险发生率31. 3%。随访时间7~80个月,平均随访(46. 14±10. 52)个月。所有患者中,复发91例(39. 6%),死亡43例(18. 7%),1年复发率10%(23/230)、3年复发率28. 3%(65/230)、5年复发率35. 2%(81/230); 1年病死率1. 7%(4/230)、3年病死率12. 2%(28/230)、5年病死率16. 1%(37/230)。其中营养风险患者复发37例(51...

     

  • [1] AKINYEMIJU T, ABERA S, AHMED M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to2015 at the global, regional, and national level:Results from the global burden of disease study 2015[J]. JAMA Oncol, 2017, 3 (12) :1683-1691.
    [2] TORZILLI G, BELGHITI J, KOKUDO N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers[J]. Ann Surg, 2013, 257 (5) :929-937.
    [3] LIU J, GAO CD, ZHANG LX. Influence of neutrophil-lymphocyte ratio on prognosis of liver cancer:A meta-analysis[J].J Clin Hepatol, 2017, 33 (7) :1305-1309. (in Chinese) 刘健, 高驰丹, 张立鑫, 等.中性粒细胞与淋巴细胞比值对肝癌预后影响的Meta分析[J].临床肝胆病杂志, 2017, 33 (7) :1305-1309.
    [4] CHEN K, ZHAN MX, HU BS, et al. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma[J]. Oncol Lett, 2018, 15 (1) :315-323.
    [5] LI YF, NIE RC, WU T, et al. Prognostic value of the nutritional risk screening 2002 scale in metastatic gastric cancer:A large-scale cohort study[J]. J Cancer, 2019, 10 (1) :112-119.
    [6] IILLA P, MARCELA T, JANA S. Screening of malnutrition risk versus indicators of nutritional status and systemic inflammatory response in newly diagnosed lung cancer patients[J]. Klin Onkol, 2014, 27 (4) :261-268.
    [7] WANG J, YU BQ, YE YJ, et al. Predictive value of nutritional risk screening 2002 and prognostic nutritional index for esophageal cancer patients undergoing definitive radiochemotherapy[J]. Nutr Cancer, 2018, 70 (6) :879-885.
    [8] CHUA DW, XIN KY, XIN LY, et al. Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118 (8) :1227-1236.
    [9] Liver Surgery Group, Surgical Society of Chinese Medical Association. Expert consensus on selection of surgical treatments for hepatocellular carcinoma (2016 3rd edition) [J]. Chin J Dig Surg, 2017, 16 (2) :113-115. (in Chinese) 中华医学会外科学分会肝脏外科学组.肝细胞癌外科治疗方法的选择专家共识 (2016年第3次修订) [J].中华消化外科杂志, 2017, 16 (2) :113-115.
    [10] KONDRUP J, RASMUSSE HH, HAMBERG O, et al. Nutritional risk screening (NRS 2002) :A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22 (3) :321-336.
    [11] LIU AX, WANG HQ, BO WT, et al. Clinical efficacy and prognostic factors analysis of hepatectomy for hepatocellular carcinoma[J]. Chin J Dig Surg, 2019, 18 (4) :368-374. (in Chinese) 刘爱祥, 王海清, 薄文滔, 等.肝细胞癌肝切除术的临床疗效及预后因素分析[J].中华消化外科杂志, 2019, 18 (4) :368-374.
    [12] OMATE M, LESMANA LA, TATEISHI R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4 (2) :439-474.
    [13] ZHANG TT, ZHAO XQ, LIU Z, et al. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy:A retrospective study of 601 Chinese patients[J].Clin Transl Oncol, 2016, 18 (8) :831-840.
    [14] ARENDS JJ. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36 (1) :11-48.
    [15] WOO SM, PARK JW, LEE WJ, et al. Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B[J]. Gut Liver, 2011, 5 (1) :82-87.
    [16] HAN B, DING YT, BIAN XJ, et al. Clinical value of preoperative nutritional support therapy in the hepatectomy of patients with nutritional risk:A prospective study[J]. Chin J Dig Surg, 2017, 16 (12) :1183-1190. (in Chinese) 韩冰, 丁义涛, 卞晓洁, 等.术前营养支持治疗在有营养风险患者肝切除术中临床价值的前瞻性研究[J].中华消化外科杂志, 2017, 16 (12) :1183-1190.
    [17] SCHUTTE K, TIPPELT B, SCHULZ C, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC) [J]. Clin Nutr, 2014, 34 (6) :1122-1127.
    [18] ALESSIO M, SHEEVA J, VALENTINA M. The challenges of nutritional assessment in cirrhosis[J]. Curr Nutr Rep, 2017, 6 (3) :274-280.
    [19] TANDON P, RAMAN M, MOURTZAKIS M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2016, 65 (3) :1044-1057.
    [20] KIM JH, SINN DH, GWAK GY, et al. Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients[J]. J Gastroenterol Hepatol, 2017, 32 (5) :1100-1106.
  • 加载中
计量
  • 文章访问数:  1388
  • HTML全文浏览量:  46
  • PDF下载量:  247
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-04-11
  • 出版日期:  2019-09-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回